ResearcherUniversity of WashingtonNo recent work listed
Ryan Blair O'Malley
Matched on ORCID iD 0000-0002-5338-3354; OpenAlex author ID A5040638867. Sources: ClinicalTrials.gov.
Their work
- Papers
- 2
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2017: 1 trial · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 2
- CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging. Co-author DOI 10.1007/s00261-022-03638-7↗
- Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-020-02786-y↗
Trials 1
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carolyn L. Wang · 2 shared papers, 2021–2022 · strength 0.30
- Paper CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging. DOI 10.1007/s00261-022-03638-7↗
- Paper Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal a… DOI 10.1007/s00261-020-02786-y↗
- Erik V. Soloff · 2 shared papers, 2021–2022 · strength 0.30
- Paper CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging. DOI 10.1007/s00261-022-03638-7↗
- Paper Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal a… DOI 10.1007/s00261-020-02786-y↗
- Andrew L. Coveler · 2 shared papers, 2021–2022 · strength 0.30
- Paper CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging. DOI 10.1007/s00261-022-03638-7↗
- Paper Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal a… DOI 10.1007/s00261-020-02786-y↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.